Schedule 13D ownership disclosure

Dimension Therapeutics, Inc.

Security class unavailable · CUSIP: 25433V105

Event date: 2015-10-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-15-361496
Form type
SC 13D
Filer
Dimension Therapeutics, Inc.
CIK
CIK 1592288
Filed
Nov 02, 2015
Reporting period
Oct 22, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub